abstract |
The present invention provides a method of treating an autoimmune disease in a subject by administering an interferon antagonist and a Flt3 ligand (Flt3L) antagonist. The present invention provides compositions comprising one or more interferon antagonists, and one or more Flt3L antagonists, in vitro assays for determining the subject's risk of developing an autoimmune disease, and particularly for use in this assay. A kit is also provided. |